Home Free urinary sialic acid levels may be elevated in patients with pneumococcal sepsis
Article
Licensed
Unlicensed Requires Authentication

Free urinary sialic acid levels may be elevated in patients with pneumococcal sepsis

  • Sarah E. Donoghue EMAIL logo , Oliver Heath , James Pitt , Kai Mun Hong , Maria Fuller and Joel Smith
Published/Copyright: August 25, 2022

Abstract

Objectives

Urine free sialic acid (UFSA) is an important diagnostic biomarker for sialuria (GNE variants) and infantile sialic acid storage disease/Salla disease (SLC17A5 variants). Traditionally, UFSA has been measured using specific single-plex methodology in relatively small cohorts of patients with clinical symptoms suggestive of these disorders. The use of multiplex tandem mass spectrometry urine screening (UMSMS) has meant that UFSA can be measured semi-quantitatively in a much larger cohort of patients being investigated for suspected metabolic disorders. We hypothesised that the neuraminidase of Streptococcus pneumoniae may release free sialic acid from endogenous sialylated glycoconjugates and result in increased UFSA levels.

Methods

We conducted a retrospective review of clinical records of patients who were identified as having S. pneumoniae infection and who also had UMSMS at the time of their acute infection.

Results

We identified three cases of increased UFSA detected by UMSMS screening that were secondary to S. pneumoniae sepsis. Additional testing ruled out genetic causes of increased UFSA in the first patient. All three patients had overwhelming sepsis with multiorgan dysfunction which was fatal. Glycosylation abnormalities consistent with the removal of sialic acid were demonstrated in serum transferrin patterns in one patient.

Conclusions

We have demonstrated in a retrospective cohort that elevation of UFSA levels have been observed in cases of S. pneumoniae sepsis. This expands our knowledge of UFSA as a biomarker in human disease. This research demonstrates that infection with organisms with neuraminidase activity should be considered in patients with unexplained increases in UFSA.


Corresponding author: Sarah E. Donoghue, Department of Metabolic Medicine, The Royal Children’s Hospital, Melbourne, VIC, Australia; and Department of Biochemical Genetics, Victorian Clinical Genetics Service, Murdoch Children’s Research Institute, Melbourne, VIC, Australia, E-mail:

Acknowldgments

We would like to acknowledge the laboratory staff at VCGS and SA Pathology for performing the screening and quantitation of urine free sialic acid levels.

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: The local Institutional Review Board provided ethics review for this study (ERM:63070).

References

1. Varki, A. Sialic acids in human health and disease. Trends Mol Med 2008;14:351–60. https://doi.org/10.1016/j.molmed.2008.06.002.Search in Google Scholar

2. Sears, P, Wong, CH. Enzyme action in glycoprotein synthesis. Cell Mol Life Sci 1998;54:223–52. https://doi.org/10.1007/s000180050146.Search in Google Scholar

3. Gabay, C, Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448–54. https://doi.org/10.1056/nejm199902113400607.Search in Google Scholar

4. Sillanaukee, P, Pönniö, M, Jääskeläinen, IP. Occurrence of sialic acids in healthy humans and different disorders. Eur J Clin Invest 1999;29:413–25. https://doi.org/10.1046/j.1365-2362.1999.00485.x.Search in Google Scholar

5. Yuki, N. Carbohydrate mimicry: a new paradigm of autoimmune diseases. Curr Opin Immunol 2005;17:577–82. https://doi.org/10.1016/j.coi.2005.09.004.Search in Google Scholar

6. Hughes, RA, Cornblath, DR. Guillain-Barré syndrome. Lancet 2005;366:1653–66. https://doi.org/10.1016/s0140-6736(05)67665-9.Search in Google Scholar

7. Liu, YC, Yu, MM, Chai, YF, Shou, ST. Sialic acids in the immune response during sepsis. Front Immunol 2017;8:1601. https://doi.org/10.3389/fimmu.2017.01601.Search in Google Scholar

8. Jiang, YN, Cai, X, Zhou, HM, Jin, WD, Zhang, M, Zhang, Y, et al.. Diagnostic and prognostic roles of soluble CD22 in patients with Gram-negative bacterial sepsis. Hepatobiliary Pancreat Dis Int 2015;14:523–9. https://doi.org/10.1016/s1499-3872(15)60394-0.Search in Google Scholar

9. Ozben, T. Elevated serum and urine sialic acid levels in renal diseases. Ann Clin Biochem 1991;28:44–8. https://doi.org/10.1177/000456329102800107.Search in Google Scholar PubMed

10. Huang, X, Yao, Q, Zhang, L, Tian, Z. The serum SA levels are significantly increased in sepsis but decreased in cirrhosis. Prog Mol Biol Transl Sci 2019;162:335–48. https://doi.org/10.1016/bs.pmbts.2019.01.009.Search in Google Scholar PubMed

11. Piagnerelli, M, Boudjeltia, KZ, Nuyens, V, De Backer, D, Su, F, Wang, Z, et al.. Rapid alterations in transferrin sialylation during sepsis. Shock 2005;24:48–52. https://doi.org/10.1097/01.shk.0000168524.20588.67.Search in Google Scholar PubMed

12. Waters, PJ, Lewry, E, Pennock, CA. Measurement of sialic acid in serum and urine: clinical applications and limitations. Ann Clin Biochem 1992;29:625–37. https://doi.org/10.1177/000456329202900603.Search in Google Scholar PubMed

13. Di Rocco, M, Gatti, R, Gandullia, P, Barabino, A, Picco, P, Borrone, C. Report on two patients with Costello syndrome and sialuria. Am J Med Genet 1993;47:1135–40. https://doi.org/10.1002/ajmg.1320470737.Search in Google Scholar PubMed

14. Suwannarat, P. Disorders of free sialic acid. Mol Genet Metabol 2005;85:85–7. https://doi.org/10.1016/j.ymgme.2005.04.005.Search in Google Scholar PubMed

15. Wen, XY, Tarailo-Graovac, M, Brand-Arzamendi, K, Willems, A, Rakic, B, Huijben, K, et al.. Sialic acid catabolism by N-acetylneuraminate pyruvate lyase is essential for muscle function. JCI Insight 2018;3. https://doi.org/10.1172/jci.insight.122373.Search in Google Scholar PubMed PubMed Central

16. Pitt, JJ, Eggington, M, Kahler, SG. Comprehensive screening of urine samples for inborn errors of metabolism by electrospray tandem mass spectrometry. Clin Chem 2002;48:1970–80. https://doi.org/10.1093/clinchem/48.11.1970.Search in Google Scholar

17. van der Ham, M, Prinsen, BH, Huijmans, JG, Abeling, NG, Dorland, B, Berger, R, et al.. Quantification of free and total sialic acid excretion by LC-MS/MS. J Chromatogr, B: Anal Technol Biomed Life Sci 2007;848:251–7. https://doi.org/10.1016/j.jchromb.2006.10.066.Search in Google Scholar PubMed

18. Cámara, M, Boulnois, GJ, Andrew, PW, Mitchell, TJ. A neuraminidase from Streptococcus pneumoniae has the features of a surface protein. Infect Immun 1994;62:3688–95. https://doi.org/10.1128/IAI.62.9.3688-3695.1994.Search in Google Scholar PubMed PubMed Central

19. Chang, YC, Uchiyama, S, Varki, A, Nizet, V. Leukocyte inflammatory responses provoked by pneumococcal sialidase. mBio 2012;3:e00220–11. https://doi.org/10.1128/mBio.00220-11.Search in Google Scholar PubMed PubMed Central

20. Quintana, E, Gala, S, García-Cazorla, A, Montero, R, Muñoz-Almagro, C, Vilaseca, MA, et al.. Secondary alteration of the transferrin isoelectric focusing pattern in a case of bacterial meningitis. J Inherit Metab Dis 2007;30:267. https://doi.org/10.1007/s10545-007-0530-1.Search in Google Scholar PubMed

21. Martinez, NN, Lipke, M, Robinson, J, Wilcken, B. Sialuria: ninth patient described has a novel mutation in GNE. JIMD Rep 2019;44:17–21. https://doi.org/10.1007/8904_2018_117.Search in Google Scholar PubMed PubMed Central

22. Aula, N, Salomäki, P, Timonen, R, Verheijen, F, Mancini, G, Månsson, JE, et al.. The spectrum of SLC17A5-gene mutations resulting in free sialic acid-storage diseases indicates some genotype-phenotype correlation. Am J Hum Genet 2000;67:832–40. https://doi.org/10.1086/303077.Search in Google Scholar PubMed PubMed Central

Received: 2022-05-24
Accepted: 2022-08-16
Published Online: 2022-08-25
Published in Print: 2022-10-26

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Measuring FGF23 in clinical practice: dream or reality?
  4. Reviews
  5. Fibroblast growth factor 23: translating analytical improvement into clinical effectiveness for tertiary prevention in chronic kidney disease
  6. Pursuing appropriateness of laboratory tests: a 15-year experience in an academic medical institution
  7. General Clinical Chemistry and Laboratory Medicine
  8. Moving average quality control of routine chemistry and hematology parameters – a toolbox for implementation
  9. Practical application of European biological variation combined with Westgard Sigma Rules in internal quality control
  10. Total bilirubin assay differences may cause inconsistent treatment decisions in neonatal hyperbilirubinaemia
  11. Early predictors of abnormal MRI patterns in asphyxiated infants: S100B protein urine levels
  12. Interlaboratory comparison study of immunosuppressant analysis using a fully automated LC-MS/MS system
  13. Analytical evaluation and bioclinical validation of new aldosterone and renin immunoassays
  14. Improving clinical performance of urine sediment analysis by implementation of intelligent verification criteria
  15. Clinical evaluation of the OC-Sensor Pledia calprotectin assay
  16. Serous body fluid evaluation using the new automated haematology analyser Mindray BC-6800Plus
  17. Analysis of cryoproteins with a focus on cryofibrinogen: a study on 103 patients
  18. Reference Values and Biological Variations
  19. Within-subject biological variation estimates using an indirect data mining strategy. Spanish multicenter pilot study (BiVaBiDa)
  20. Short-term biological variation of serum glial fibrillary acidic protein
  21. Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort
  22. Serum GFAP – reference interval and preanalytical properties in Danish adults
  23. Determination of pediatric reference limits for 10 commonly measured autoantibodies
  24. Hematology and Coagulation
  25. Arterial and venous blood sampling is equally applicable for coagulation and fibrinolysis analyses
  26. Infectious Diseases
  27. Free urinary sialic acid levels may be elevated in patients with pneumococcal sepsis
  28. Letters to the Editor
  29. Thyroid stimulating hormone: biased estimate of allowable bias
  30. Letter to the Editor relating to Clin Chem Lab Med 2022;60(9):1365–72
  31. Reply to the Letter of Sun et al. [1] relating to Clin Chem Lab Med 2022;60(9):1365–72
  32. Prognostic significance of smudge cell percentage in chronic lymphocytic leukemia. Facts or artifacts? Methodological considerations and literature review
  33. Detection of a monoclonal component after pediatric liver transplantation: a case report
  34. Reporting magnesium critical results: clinical impact on pregnant women and neonates
  35. Congress Abstracts
  36. 54th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC – Laboratory Medicine)
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2022-0473/html
Scroll to top button